2.1 Mechanisms Probiotics (sometimes referred to as psychobiotics in this context) can modulate communication between the microbiota, gut and brain through multiple pathways
Conclusion More than thirty years have passed since the gut hormone GLP- 1 was first shown to lower blood sugar levels in people with T2DM [152]
Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD
You can work with your provider to implement any lifestyle shifts and medication changes accordingly
And with the right care and support, you can feel more prepared, more confident, and more in control from the very beginning
www.nature.com , Torekov, S